Search research articles
Contact Us
Filters
Showing results (41-50 of 102) with videos related to
Page
of 11
Sort By:
European Heart Journal
|
November 30, 2010
Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction)
Cecilia Linde, Stuart Mealing, Neil Hawkins, et al.
The Cochrane Database of Systematic Reviews
|
April 15, 2016
Management strategies for pancreatic pseudocysts
Kurinchi Selvan Gurusamy, Elena Pallari, Neil Hawkins, et al.
Cardiovascular Therapeutics
|
September 9, 2021
Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis
Rupert Bauersachs, Olivia Wu, Neil Hawkins, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
September 15, 2005
Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model
Neil Hawkins, David Epstein, Michael Drummond, et al.
Experimental Hematology & Oncology
|
February 21, 2013
The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysis
Stuart Mealing, Leticia Barcena, Neil Hawkins, et al.
Pharmacoeconomics
|
October 14, 2025
Cure Models: What is Meant by a Survival 'Plateau', and Do Experts Agree on What Constitutes One?
Dan Jackson, Michael Sweeting, Robert Hettle, et al.
Journal of Market Access & Health Policy
|
August 28, 2024
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison
David Cherney, Kerstin Folkerts, Paul Mernagh, et al.
BMJ Open
|
January 29, 2013
The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients
Shehzad Ali, Stuart Mealing, Neil Hawkins, et al.
Urology
|
February 22, 2019
The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysis
Greta Lozano-Ortega, David Walker, Basia Rogula, et al.
International Journal of Technology Assessment in Health Care
|
November 1, 2022
Economic evaluation of genomic/genetic tests: a review and future directions
Janet Bouttell, Robert Heggie, Karin Oien, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 102) with videos related to
Sort By:
Page
of 11
European Heart Journal
|
November 30, 2010
Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction)
Cecilia Linde, Stuart Mealing, Neil Hawkins, et al.
The Cochrane Database of Systematic Reviews
|
April 15, 2016
Management strategies for pancreatic pseudocysts
Kurinchi Selvan Gurusamy, Elena Pallari, Neil Hawkins, et al.
Cardiovascular Therapeutics
|
September 9, 2021
Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis
Rupert Bauersachs, Olivia Wu, Neil Hawkins, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
September 15, 2005
Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model
Neil Hawkins, David Epstein, Michael Drummond, et al.
Experimental Hematology & Oncology
|
February 21, 2013
The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysis
Stuart Mealing, Leticia Barcena, Neil Hawkins, et al.
Pharmacoeconomics
|
October 14, 2025
Cure Models: What is Meant by a Survival 'Plateau', and Do Experts Agree on What Constitutes One?
Dan Jackson, Michael Sweeting, Robert Hettle, et al.
Journal of Market Access & Health Policy
|
August 28, 2024
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison
David Cherney, Kerstin Folkerts, Paul Mernagh, et al.
BMJ Open
|
January 29, 2013
The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients
Shehzad Ali, Stuart Mealing, Neil Hawkins, et al.
Urology
|
February 22, 2019
The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysis
Greta Lozano-Ortega, David Walker, Basia Rogula, et al.
International Journal of Technology Assessment in Health Care
|
November 1, 2022
Economic evaluation of genomic/genetic tests: a review and future directions
Janet Bouttell, Robert Heggie, Karin Oien, et al.
Page
of 11